This is a preview of subscription content, log in via an institution to check access.
Reference
Lomas J, et al. Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease. PharmacoEconomics-Open : 14 Feb 2018. Available from: URL: https://doi.org/10.1007/s41669-018-0068-1
Rights and permissions
About this article
Cite this article
Cost categories impact cost-effectiveness evaluations. PharmacoEcon Outcomes News 797, 10 (2018). https://doi.org/10.1007/s40274-018-4719-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4719-3